Clinical Trials Logo

Filter by:
NCT ID: NCT02488473 Completed - Healthy Clinical Trials

Does Perineural Dexmedetomidine Prolong Duration of a Nerve Block?

Start date: August 2015
Phase: Phase 2
Study type: Interventional

Brief Summary: The aim of this trial is to investigate if dexmedetomidine prolongs the duration of an adductor canal block. By using healthy volunteers the investigators can perform a bilateral adductor canal block and thereby control for a systemic effect to clarify if the effect is actually peripheral or systemic. The investigators hypothesis is that dexmedetomidine as an adjunct to a local anaesthetic prolongs the duration of a peripheral nerve block by a peripheral mechanism.

NCT ID: NCT02486419 Completed - Clinical trials for Nonshivering Thermogenisis

Human Neck Brown Adipose Tissue mRNA Profile, a Seasonal Variation Study.

Start date: February 2015
Phase: N/A
Study type: Observational

The primary objective in this study is to examine the seasonal variation in genetic markers in the deep neck adipose tissue in humans. Human adipose tissue biopsies are taken from patients admitted for elective surgery in the neck. During the surgical procedure a subcutaneous adipose tissue biopsy is taken for reference.

NCT ID: NCT02486276 Completed - Migraine Clinical Trials

The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache

Start date: June 2015
Phase: N/A
Study type: Interventional

To develop a pragmatic migraine model the investigators will induce headache in healthy volunteers and in patients with migraine without aura with a phosphodiesterase inhibitor (cilostazol). If the headache responds to sumatriptan, the model can be used to test new drug candidates.

NCT ID: NCT02485340 Completed - Migraine Clinical Trials

The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache

Start date: April 2015
Phase: N/A
Study type: Interventional

To develop a pragmatic migraine model the investigators will induce headache in healthy volunteers and in patients with migraine without aura with a long lasting Nitrogen Oxide (NO) donor. If the headache responds to sumatriptan, the model can be used to test new drug candidates.

NCT ID: NCT02483585 Completed - Migraine Clinical Trials

Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention

ARISE
Start date: July 20, 2015
Phase: Phase 3
Study type: Interventional

To evaluate the effect of erenumab compared to placebo on the change from baseline in monthly migraine days, in adults with episodic migraine.

NCT ID: NCT02482090 Completed - Clinical trials for Metastatic Ovarian Cancer

TIL Therapy for Metastatic Ovarian Cancer

Start date: July 2015
Phase: Phase 1
Study type: Interventional

Adoptive T cell therapy with tumor infiltrating lymphocytes (TIL) has achieved impressive clinical results with durable complete responses in patients with metastatic melanoma. The TILs are isolated from patients own tumor tissue followed by in vitro expansion and activation for around 4-6 weeks. Before TIL infusion the patients receive 1 week of preconditioning chemotherapy with cyclophosphamide and fludarabine. After TIL infusion Interleukin-2 is administered to support T cell acitivation and proliferation in vivo. Recent studies suggest, that TIL therapy works in other cancers than Metastatic Melanoma, including Ovarian Cancer. In this study TIL therapy is administered to patients with metastatic Ovarian Cancer.

NCT ID: NCT02481830 Completed - Lung Cancer Clinical Trials

Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer

CheckMate331
Start date: September 14, 2015
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the overall survival of nivolumab versus chemotherapy in subjects with relapsed SCLC.

NCT ID: NCT02478840 Completed - Alpha-Mannosidosis Clinical Trials

Evaluation of Long-term Efficacy of Treatment With Lamazym

rhLAMAN-10
Start date: February 2015
Phase: Phase 3
Study type: Interventional

The overall objective is to evaluate the long-term efficacy of Lamazym i.v. treatment in patients with alpha-Mannosidosis previously enrolled in Lamazym trials and currently receiving the treatment according to the AfterCare Program.

NCT ID: NCT02478385 Completed - Pregnancy Clinical Trials

Birth Environment of the Future

Start date: May 2015
Phase: N/A
Study type: Interventional

The main purpose of this study is to explore the impact of the birth environment on women's birth experience and relevant birth outcomes in the experimental Labour room compared to a standard Labour room.

NCT ID: NCT02477644 Completed - Ovarian Cancer Clinical Trials

Platine, Avastin and OLAparib in 1st Line

PAOLA-1
Start date: May 6, 2015
Phase: Phase 3
Study type: Interventional

Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and Bevacizumab Concurrent with Chemotherapy and in Maintenance.